HotDrStockNews'  Instablog

Send Message
  • XRIT, MRX, OSIR, NHPR, BRCD, SNTA - Watch List for Monday Feb. 28, 2011  0 comments
    Feb 27, 2011 3:42 PM | about stocks: XRIT, VRX, OSIR, BRCD, MDGL




    snta SNTA, Synta Pharmaceuticals Corp.


    SNTA is a biopharmaceutical company focused on discovering, developing, and commercializing novel pharmaceutical products for extending and enhancing the lives of patients with severe medical conditions, including cancer and chronic inflammatory disease.

    SNTA reported that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer (NSCLC) were presented at the International Association for the Study of Lung Cancer (IASLC) 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting. The trial is ongoing; final results are expected later this year.

    Read the rest of Synta's drug on clinical trial plus other news at:

Back To HotDrStockNews' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.